All reasonable conclusions save one. IF the Hema safety study once submitted ( for a 28 day trial could be submitted already) is accepted and full FDA approval AND Orphan Drug Status are given. Then this goes up by 500 to 1000 pct in a day. There is no chasing, it's gone. Both approvals are very close IMO.